These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4833981)

  • 1. Letter: Biochemical basis of malignant hyperpyrexia.
    Bowers E
    Br Med J; 1974 Jun; 2(5919):614. PubMed ID: 4833981
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium and magnesium contents of malignant hyperpyrexia-susceptible human muscle.
    Bennett D; Cain PA; Ellis FR; Louis CF; Stanton M
    Br J Anaesth; 1977 Oct; 49(10):979-82. PubMed ID: 921875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical studies on malignant hyperpyrexia.
    Pennington RJ; Worsfold M
    Proc R Soc Med; 1973 Jan; 66(1 Pt 1):69-70. PubMed ID: 4266079
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical basis of malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1974 May; 2(5913):241-4. PubMed ID: 4827070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology of malignant hyperpyrexia.
    Br Med J; 1973 Feb; 1(5848):249. PubMed ID: 4685313
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of dantrolene on skeletal-muscle sarcoplasmic-reticulum function in malignant hyperpyrexia in pigs.
    White MD; Collins JG; Denborough MA
    Biochem J; 1983 May; 212(2):399-405. PubMed ID: 6224481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: Treatment of idiopathic malignant hyperthermia.
    Saviello GM
    Arch Ophthalmol; 1976 May; 94(5):867. PubMed ID: 1267662
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Procaine for malignant hyperthermia.
    Heffron JJ; Mitchell G
    N Engl J Med; 1975 Jan; 292(5):266-7. PubMed ID: 1110700
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant hyperpyrexia and oxygen consumption.
    Philpott I
    Anaesth Intensive Care; 1990 Aug; 18(3):422-3. PubMed ID: 2221339
    [No Abstract]   [Full Text] [Related]  

  • 10. Defect of intracellular calcium channels is culprit in malignant hyperthermia.
    Merz B
    JAMA; 1986 Feb; 255(6):710-1. PubMed ID: 2418221
    [No Abstract]   [Full Text] [Related]  

  • 11. Sarcoplasmic reticulum calcium uptake in cryostat sections of skeletal muscle from malignant hyperthermia patients and controls.
    Allen PD; Ryan JF; Jones DE; Mabuchi K; Virga A; Roberts J; Sreter F
    Muscle Nerve; 1986 Jun; 9(5):474-5. PubMed ID: 3724793
    [No Abstract]   [Full Text] [Related]  

  • 12. Dantrolene reduces myoplasmic free [Ca2+] in patients with malignant hyperthermia.
    López JR; López M; Allen P
    Acta Cient Venez; 1990; 41(2):135-7. PubMed ID: 2135562
    [No Abstract]   [Full Text] [Related]  

  • 13. Dysregulation of the gain of CICR through ryanodine receptor1 (RyR1): the putative mechanism underlying malignant hyperthermia.
    Ogawa Y
    Adv Exp Med Biol; 2007; 592():287-94. PubMed ID: 17278373
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium content and contracture in isolated muscle of malignant hyperthermia in pigs.
    Nelson TE; Chausmer AB
    J Pharmacol Exp Ther; 1981 Oct; 219(1):107-11. PubMed ID: 7288598
    [No Abstract]   [Full Text] [Related]  

  • 15. Porcine malignant hyperthermia susceptibility: increased calcium-sequestering activity of skeletal muscle sarcoplasmic reticulum.
    O'Brien PJ
    Can J Vet Res; 1986 Jul; 50(3):329-37. PubMed ID: 3742368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ca2+]i in muscles of malignant hyperthermia susceptible pigs determined in vivo with Ca2+ selective microelectrodes.
    Lopez JR; Alamo LA; Jones DE; Papp L; Allen PD; Gergely J; Sréter FA
    Muscle Nerve; 1986 Jan; 9(1):85-6. PubMed ID: 3951486
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Myopathies and malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1974 Aug; 3(5929):520. PubMed ID: 4414306
    [No Abstract]   [Full Text] [Related]  

  • 18. Porcine malignant hyperthermia susceptibility: hypersensitive calcium-release mechanism of skeletal muscle sarcoplasmic reticulum.
    O'Brien PJ
    Can J Vet Res; 1986 Jul; 50(3):318-28. PubMed ID: 3742367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ca2+ transport and (Ca2+ - Mg2+) ATPase activity in vesicles of the sarcoplasmic reticulum of patients susceptible to malignant hyperthermia syndrome].
    Condrescu M; López JR; Alamo L; Medina P
    Acta Cient Venez; 1985; 36(5-6):407-8. PubMed ID: 2944339
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug treatment of malignant hyperpyrexia.
    Austin KL; Denborough MA
    Anaesth Intensive Care; 1977 Aug; 5(3):207-13. PubMed ID: 900461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.